Retractable Technologies (NYSE:RVP) Now Covered by StockNews.com

Equities researchers at StockNews.com began coverage on shares of Retractable Technologies (NYSE:RVP) in a research report issued to clients and investors on Saturday. The firm set a “hold” rating on the stock.

Retractable Technologies Price Performance

Shares of RVP opened at $0.73 on Friday. The firm has a market capitalization of $21.88 million, a price-to-earnings ratio of -2.81 and a beta of 2.06. Retractable Technologies has a 52 week low of $0.71 and a 52 week high of $1.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 6.54 and a current ratio of 9.51. The business’s fifty day moving average price is $0.84 and its two-hundred day moving average price is $1.00.

Retractable Technologies (NYSE:RVP) last issued its quarterly earnings data on Wednesday, August 14th. The company reported ($0.48) earnings per share (EPS) for the quarter. Retractable Technologies had a negative return on equity of 18.67% and a negative net margin of 46.72%. The company had revenue of $6.03 million for the quarter.

Insider Activity

In other Retractable Technologies news, CEO Thomas J. Shaw acquired 71,422 shares of the business’s stock in a transaction on Friday, September 20th. The stock was purchased at an average price of $0.82 per share, with a total value of $58,566.04. Following the acquisition, the chief executive officer now directly owns 14,743,907 shares of the company’s stock, valued at approximately $12,090,003.74. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders have purchased 202,874 shares of company stock valued at $176,544 over the last ninety days. 55.00% of the stock is currently owned by company insiders.

Institutional Trading of Retractable Technologies

A hedge fund recently bought a new stake in Retractable Technologies stock. PFG Investments LLC purchased a new stake in shares of Retractable Technologies, Inc. (NYSE:RVP) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm purchased 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned about 0.12% of Retractable Technologies at the end of the most recent quarter. 7.58% of the stock is owned by hedge funds and other institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.